Skip to main content

Extraction of clinical phenotypes for Alzheimer disease dementia from clinical notes using natural language processing

Cite this dataset

Oh, Inez et al. (2023). Extraction of clinical phenotypes for Alzheimer disease dementia from clinical notes using natural language processing [Dataset]. Dryad.



There is much interest in utilizing clinical data for developing prediction models for Alzheimer disease (AD) risk, progression, and outcomes. Existing studies have mostly utilized curated research registries, image analysis, and structured Electronic Health Record (EHR) data. However, much critical information resides in relatively inaccessible unstructured clinical notes within the EHR.

Materials and Methods

We developed a natural language processing (NLP)-based pipeline to extract AD-related clinical phenotypes, documenting strategies for success and assessing the utility of mining unstructured clinical notes. We evaluated the pipeline against gold-standard manual annotations performed by two clinical dementia experts for AD-related clinical phenotypes including medical comorbidities, biomarkers, neurobehavioral test scores, behavioral indicators of cognitive decline, family history, and neuroimaging findings.


Documentation rates for each phenotype varied in the structured versus unstructured EHR. Inter-annotator agreement was high (Cohen’s kappa = 0.72–1) and positively correlated with the NLP-based phenotype extraction pipeline’s performance (average F1-score = 0.65-0.99) for each phenotype.


We developed an automated NLP-based pipeline to extract informative phenotypes that may improve the performance of eventual machine-learning predictive models for AD. In the process, we examined documentation practices for each phenotype relevant to the care of AD patients and identified factors for success.


Success of our NLP-based phenotype extraction pipeline depended on domain-specific knowledge and focus on a specific clinical domain instead of maximizing generalizability.


We developed a natural language processing (NLP)-based pipeline which contains independent NLP modules that target the extraction of ten clinical phenotypes relevant to Alzheimer disease dementia progression. The pipeline was trained on unstructured clinical notes originating from Allscripts TouchWorks associated with AD dementia patient office vsits that occurred between June 1, 2013, to May 31, 2018, extracted from the Washington University in St. Louis Research Data Core (RDC), a repository of patient clinical data from BJC HealthCare and Washington University Physicians. The targeted phenotypes included neurobehavioral test scores (Clinical Dementia Rating and Mini-Mental State Exam) and their corresponding test dates, comorbidities (hypertension and depression), neuroimaging findings (presence of atrophy or infarct), behavioral indicators of dementia (repeating and misplacing), biomarker levels (total and phosphorylated tau protein levels), and family history (whether there was a family history of dementia, and if yes, which family member(s)).

The clinical notes extracted from EHR were in rich text format (RTF) contained within tab-delimited files (TXT) alongside metadata such as the patient medical record number, author, and date authored. These were preprocessed before being analyzed by the NLP-based phenotype extraction pipeline. This entailed converting the TXT files to comma-separated files (CSV), accounting for additional tab, quote, and newline characters present, and stripping the RTF formatting.

Usage notes

Data preprocessing steps were performed using the Python Pandas and striprtf (version 0.0.10) packages.

Linguamatics I2E query files (*.i2qy) and Enterprise Architect Simulation Library (EASL) code for each NLP module can be found on the Linguamatics Community webpage (, accessible with the creation of a free account. Linguamatics I2E software is required to open the query files (*.i2qy) directly, but the logic underlying the NLP modules can be understood by referencing the EASL code.


Centene Corporation (United States, Award: P19-00559